Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study - Fischer, L; Saliba, F; Kaiser, G M (Transplantation, 2015)
et al.